DNA methylation and cancer.

[1]  Peter A. Jones,et al.  Rethinking how DNA methylation patterns are maintained , 2009, Nature Reviews Genetics.

[2]  K. Robertson,et al.  DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer. , 2009, Cancer research.

[3]  Ryosuke Ohsawa,et al.  Epigenetic inheritance of an inducibly nucleosome-depleted promoter and its associated transcriptional state in the apparent absence of transcriptional activators , 2009, Epigenetics & Chromatin.

[4]  Michael Q. Zhang,et al.  High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. , 2009, Genome research.

[5]  P. Goyal,et al.  Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation , 2009, Epigenetics.

[6]  Peter A. Jones,et al.  Selective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA , 2009, Molecular and Cellular Biology.

[7]  Qian Tao,et al.  Epigenetic disruption of the WNT/ß-catenin signaling pathway in human cancers , 2009, Epigenetics.

[8]  J. Issa,et al.  Targeting DNA Methylation , 2009, Clinical Cancer Research.

[9]  M. Eilers,et al.  Facilitating replication under stress: an oncogenic function of MYC? , 2009, Nature Reviews Cancer.

[10]  K. Ghoshal,et al.  A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation. , 2009, Cancer research.

[11]  Anindya Dutta,et al.  MicroRNAs in cancer. , 2009, Annual review of pathology.

[12]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[13]  A. Riggs,et al.  Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. , 2008, Cancer research.

[14]  S. Varambally,et al.  Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer , 2008, Science.

[15]  Peter A. Jones,et al.  Chromatin, cancer and drug therapies. , 2008, Mutation research.

[16]  S. Henikoff,et al.  Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks , 2008, Nature.

[17]  Gangning Liang,et al.  Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line , 2008, Proceedings of the National Academy of Sciences.

[18]  Yi Hou,et al.  Aberrant DNA methylation in 5' regions of DNA methyltransferase genes in aborted bovine clones. , 2008, Journal of genetics and genomics = Yi chuan xue bao.

[19]  Jeannie T. Lee,et al.  Antagonism between DNA and H3K27 Methylation at the Imprinted Rasgrf1 Locus , 2008, PLoS genetics.

[20]  Michael Q. Zhang,et al.  Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.

[21]  James H. Doroshow,et al.  Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU) , 2008, Cancer Chemotherapy and Pharmacology.

[22]  M. Toyota,et al.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. , 2008, Cancer research.

[23]  D. Gold,et al.  Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation , 2008, Nature Genetics.

[24]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[25]  Parantu K. Shah,et al.  Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression , 2008, Molecular systems biology.

[26]  Peter A. Jones,et al.  Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice , 2008, Cancer Prevention Research.

[27]  Dustin E. Schones,et al.  Dynamic Regulation of Nucleosome Positioning in the Human Genome , 2008, Cell.

[28]  G. Hannon,et al.  A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases , 2008, Nature Structural &Molecular Biology.

[29]  Matteo Pellegrini,et al.  Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. , 2008, Cell stem cell.

[30]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[31]  R. Jaenisch,et al.  Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice , 2008, Oncogene.

[32]  K. Mitsuya,et al.  The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA , 2007, Nature.

[33]  J. Issa,et al.  Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner. , 2007, Cancer research.

[34]  Peter A. Jones,et al.  Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. , 2007, Cancer cell.

[35]  H. Hermeking.  p53 enters the microRNA world. , 2007, Cancer cell.

[36]  J. Issa,et al.  Treatment Options in Advanced Myelodysplastic Syndrome, with Emphasis on Epigenetic Therapy , 2007, International journal of hematology.

[37]  Peter A. Jones,et al.  DNA methylation: The nuts and bolts of repression , 2007, Journal of cellular physiology.

[38]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[39]  N. Sonenberg,et al.  UHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian Cells , 2007, Science.

[40]  J. Chrivia,et al.  The Chromatin Remodeling Protein, SRCAP, Is Critical for Deposition of the Histone Variant H2A.Z at Promoters* , 2007, Journal of Biological Chemistry.

[41]  M. L. Beau,et al.  Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins , 2007, Oncogene.

[42]  C. Allis,et al.  DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA , 2007, Nature.

[43]  P. Zuzarte,et al.  Monoubiquitylation of H2A.Z Distinguishes Its Association with Euchromatin or Facultative Heterochromatin , 2007, Molecular and Cellular Biology.

[44]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[45]  S. Pradhan,et al.  Functional cooperation between HP1 and DNMT1 mediates gene silencing. , 2007, Genes & development.

[46]  Yvonne N Fondufe-Mittendorf,et al.  H2A.Z-Mediated Localization of Genes at the Nuclear Periphery Confers Epigenetic Memory of Previous Transcriptional State , 2007, PLoS biology.

[47]  Michael B. Stadler,et al.  Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.

[48]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[49]  E. Li,et al.  Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells , 2007, Nature Genetics.

[50]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[51]  Bing Li,et al.  The Role of Chromatin during Transcription , 2007, Cell.

[52]  N. Cho,et al.  Hypermethylation of CpG island loci and hypomethylation of LINE‐1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features , 2007, The Journal of pathology.

[53]  P. Laird,et al.  Epigenetic stem cell signature in cancer , 2007, Nature Genetics.

[54]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[55]  Jun S. Song,et al.  High-throughput mapping of the chromatin structure of human promoters , 2007, Nature Biotechnology.

[56]  Kelly M. McGarvey,et al.  A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.

[57]  C. Topp,et al.  Repression of Flowering in Arabidopsis Requires Activation of FLOWERING LOCUS C Expression by the Histone Variant H2A.Z[W][OA] , 2007, The Plant Cell Online.

[58]  Peter A. Jones,et al.  Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells , 2006, Cell cycle.

[59]  Peter A. Jones,et al.  Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival , 2006, Proceedings of the National Academy of Sciences.

[60]  Amos Tanay,et al.  Constitutive Nucleosome Depletion and Ordered Factor Assembly at the GRP78 Promoter Revealed by Single Molecule Footprinting , 2006, PLoS genetics.

[61]  Diane D. Liu,et al.  Expression of ΔDNMT3B Variants and Its Association with Promoter Methylation of p16 and RASSF1A in Primary Non–Small Cell Lung Cancer , 2006 .

[62]  Jianzhu Chen,et al.  Inhibition of IFN‐γ transcription by site‐specific methylation during T helper cell development , 2006 .

[63]  M. Washburn,et al.  Purification of a human SRCAP complex that remodels chromatin by incorporating the histone variant H2A.Z into nucleosomes. , 2006, Biochemistry.

[64]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[65]  G. Hannon,et al.  Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.

[66]  M. Fraga,et al.  The Polycomb group protein EZH2 directly controls DNA methylation , 2006, Nature.

[67]  Jian-Fu Chen,et al.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.

[68]  C. Burge,et al.  The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.

[69]  Peter A. Jones,et al.  Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level , 2005, Nucleic acids research.

[70]  S. Schreiber,et al.  Histone Variant H2A.Z Marks the 5′ Ends of Both Active and Inactive Genes in Euchromatin , 2005, Cell.

[71]  R. Momparler.  Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine). , 2005, Seminars in oncology.

[72]  S. Henikoff,et al.  Genome-scale profiling of histone H3.3 replacement patterns , 2005, Nature Genetics.

[73]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[74]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[75]  U. Bunz.  How Are Alkynes Scrambled? , 2005, Science.

[76]  S. Antonarakis,et al.  Meiotic and epigenetic defects in Dnmt3L-knockout mouse spermatogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[77]  J. Lieb,et al.  Evidence for nucleosome depletion at active regulatory regions genome-wide , 2004, Nature Genetics.

[78]  D. Reinberg,et al.  Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. , 2004, Genes & development.

[79]  J Seth Strattan,et al.  Removal of promoter nucleosomes by disassembly rather than sliding in vivo. , 2004, Molecular cell.

[80]  Peter A. Jones,et al.  Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[81]  J. Stamatoyannopoulos,et al.  Genome-wide identification of DNaseI hypersensitive sites using active chromatin sequence libraries. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Peter A. Jones,et al.  Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells , 2004, Molecular and Cellular Biology.

[83]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[84]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[85]  J. Issa,et al.  Comment on "Chromosomal Instability and Tumors Promoted by DNA Hypomethylation" and "Induction of Tumors in Mice by Genomic Hypomethylation" , 2003, Science.

[86]  Steven Henikoff,et al.  Phylogenomics of the nucleosome , 2003, Nature Structural Biology.

[87]  Debashis Ghosh,et al.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[88]  E. Li,et al.  Establishment and Maintenance of Genomic Methylation Patterns in Mouse Embryonic Stem Cells by Dnmt3a and Dnmt3b , 2003, Molecular and Cellular Biology.

[89]  T. Jenuwein,et al.  An epigenetic road map for histone lysine methylation , 2003, Journal of Cell Science.

[90]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[91]  R. Jaenisch,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.

[92]  Hiten D. Madhani,et al.  Conserved Histone Variant H2A.Z Protects Euchromatin from the Ectopic Spread of Silent Heterochromatin , 2003, Cell.

[93]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[94]  Tony Kouzarides,et al.  The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone Methylation* , 2003, The Journal of Biological Chemistry.

[95]  D. Reinberg,et al.  Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. , 2002, Genes & development.

[96]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[97]  Stuart L. Schreiber,et al.  Active genes are tri-methylated at K4 of histone H3 , 2002, Nature.

[98]  S. Hirohashi,et al.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[100]  Hong Duan,et al.  Role for DNA methylation in the control of cell type–specific maspin expression , 2002, Nature Genetics.

[101]  J. Holland,et al.  Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[102]  R. Jaenisch,et al.  Dnmt1 Overexpression Causes Genomic Hypermethylation, Loss of Imprinting, and Embryonic Lethality , 2002, Molecular and Cellular Biology.

[103]  T. Kouzarides.  Histone methylation in transcriptional control. , 2002, Current opinion in genetics & development.

[104]  T. Bestor,et al.  Dnmt3L and the Establishment of Maternal Genomic Imprints , 2001, Science.

[105]  P. Jones,et al.  Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. , 2001, Nucleic acids research.

[106]  S. Groshen,et al.  Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. , 2001, Journal of the National Cancer Institute.

[107]  S. Baylin,et al.  Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.

[108]  Andrew J. Bannister,et al.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain , 2001, Nature.

[109]  Karl Mechtler,et al.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins , 2001, Nature.

[110]  M. Lübbert,et al.  Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[111]  K. Lisowska,et al.  Nuclease-hypersensitive Chromatin Formed by a CpG Island in Human DNA Cloned as an Artificial Chromosome in Yeast* , 2000, The Journal of Biological Chemistry.

[112]  R J Roberts,et al.  Recombinant Human DNA (Cytosine-5) Methyltransferase , 1999, The Journal of Biological Chemistry.

[113]  R. Jaenisch,et al.  Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila , 1999, Nature Genetics.

[114]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[115]  C. Walsh,et al.  Transcription of IAP endogenous retroviruses is constrained by cytosine methylation , 1998, Nature Genetics.

[116]  E. Li,et al.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.

[117]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[118]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[119]  H. Ng,et al.  Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. , 1997, Science.

[120]  M. Ehrlich,et al.  DNA demethylation and pericentromeric rearrangements of chromosome 1. , 1997, Mutation research.

[121]  B. Dutrillaux,et al.  Hypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines , 1993, Human Genetics.

[122]  M. Surani,et al.  Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. , 1992, Genes & development.

[123]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[124]  A. Kolstø,et al.  CpG islands in mammalian gene promoters are inherently resistant to de novo methylation. , 1992, Genetic analysis, techniques and applications.

[125]  A. Riggs,et al.  Chromatin differences between active and inactive X chromosomes revealed by genomic footprinting of permeabilized cells using DNase I and ligation-mediated PCR. , 1991, Genes & development.

[126]  Adrian Bird,et al.  Alternative chromatin structure at CpG islands , 1990, Cell.

[127]  V. Ingram,et al.  Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. , 1988, Journal of molecular biology.

[128]  V. Ingram,et al.  Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[129]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[130]  Peter A. Jones,et al.  Cellular differentiation, cytidine analogs and DNA methylation , 1980, Cell.

[131]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[132]  Peter A. Jones,et al.  Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.

[133]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[134]  K. Robertson,et al.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.

[135]  A. Riggs,et al.  5-methylcytosine, gene regulation, and cancer. , 1983, Advances in cancer research.

[136]  Arthur D. Riggs,et al.  X inactivation, differentiation, and DNA methylation. , 1975, Cytogenetics and cell genetics.